enoximone
Sign in to saveAlso known as fenoximone, MDL 17,043, MDL-17,043, MDL-17043, Perfan®, Perfan
Enoximone (INN, trade name Perfan) is an imidazole phosphodiesterase inhibitor. It is used in the treatment of congestive heart failure and is selective for phosphodiesterase 3.
Research
601 papers- Enoximone.Lancet (London, England) · 1988
- Enoximone.American heart journal · 1990
- Enoximone in status asthmaticus.ERJ open research · 2020
- (Oral) enoximone in asthma.ERJ open research · 2020
- Enoximone. A review of its pharmacological properties and therapeutic potential.Drugs · 1991
via PubMed
~2 min read
Encyclopedic overview
2 sectionsContents
- References
- External links
{{Drugbox | Watchedfields = changed | verifiedrevid = 443725104 | IUPAC_name = 4-Methyl-5-{[4-(methylsulfanyl)phenyl]carbonyl}-2,3-dihydro-1H-imidazol-2-one | image = Enoximone.svg | image_class = skin-invert-image
| tradename = Perfan | Drugs.com = | pregnancy_AU = | pregnancy_US = | pregnancy_category = | legal_AU = | legal_UK = POM | legal_US = | legal_status = | routes_of_administration = Intravenous
Excerpted from Wikipedia’s “enoximone” article, available under the CC BY-SA 4.0 licence.